A detailed history of Marsico Capital Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Marsico Capital Management LLC holds 34,381 shares of NTRA stock, worth $4.95 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
34,381
Holding current value
$4.95 Million
% of portfolio
0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$117.67 - $174.0 $4.05 Million - $5.98 Million
34,381 New
34,381 $5.44 Million
Q1 2022

May 13, 2022

BUY
$30.32 - $91.33 $256,780 - $773,473
8,469 Added 14.62%
66,404 $2.7 Million
Q4 2021

Feb 14, 2022

SELL
$86.26 - $119.0 $1.14 Million - $1.58 Million
-13,265 Reduced 18.63%
57,935 $5.41 Million
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $3.33 Million - $4.2 Million
33,246 Added 87.6%
71,200 $7.94 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $1.74 Million - $2.76 Million
37,954 New
37,954 $2.74 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Marsico Capital Management LLC Portfolio

Follow Marsico Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marsico Capital Management LLC with notifications on news.